Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05558124
Title CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST